Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/04/2003US20030225126 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections
12/04/2003US20030225125 Interleukin-8 (IL-8); treating the chemokine-mediated diseases malaria, restenosis, atherosclerosis, osteoporosis, gingivitis, undesired hematopoietic stem cells release and viral diseases hepatitis, herpes, respiratory viruses
12/04/2003US20030225124 Mixing an ACE inhibitor with an alcohol to form an alcoholic dispersion; mixing a metal compound into said dispersion; and mixing said dispersion and said metal compound; stabilized ACE inhibitor is quinapril sodium or enalapril sodium
12/04/2003US20030225122 2-(S)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1H-isoquinolin -2-yl)- propionamide for example; Alzheimer's disease or senile dementia
12/04/2003US20030225120 Dihydropyridine soft drugs, and related compositions and methods
12/04/2003US20030225118 Tamsulosin, or an acid addition salt thereof with a 5 alpha-reductase inhibitor.
12/04/2003US20030225117 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
12/04/2003US20030225116 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine
12/04/2003US20030225115 Anticoagulants
12/04/2003US20030225114 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4- oxopyrimidines
12/04/2003US20030225113 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
12/04/2003US20030225111 Use of a quinazoline derivative such as 1-(2,6-dichloro-phenyl)-3-(7-(3-morpholinopropoxy)quinazolin-4-yl) urea to produce an antiangiogenic and/or vascular permeability reducing effect
12/04/2003US20030225109 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy
12/04/2003US20030225107 Cyclopropyl containing oxazolidinone antibiotics and derivatives thereof
12/04/2003US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225104 Pharmaceutical compositions for poorly soluble drugs
12/04/2003US20030225103 Method of using diketopiperazines and composition containing them
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate
12/04/2003US20030225101 Including blurred vision, eye pain, and loss of vision.
12/04/2003US20030225100 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
12/04/2003US20030225099 E.g., 1-(phenylethyl)-(2-(6-(2-pyridin-2-ylethylcarbamoyl)-pyridin-2 -yl)benzyl)carbamate; use as antiarrhythmic active compounds
12/04/2003US20030225097 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor
12/04/2003US20030225096 Administering a growth hormone secretagogue.
12/04/2003US20030225094 E.g, 4-(2-((6R,12aR)-6-benzo(1,3)dioxol-5-yl-1,4-dioxo -3,4,6,7,12,12a-hexahydro-1H-pyrazino-(1',2':1,6)pyrido(3,4-b) indol-2-yl)ethyl)-benzenesulfonamide; inhibitors of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase
12/04/2003US20030225093 Cyclic gmp-specific phosphodiesterase inhibitors
12/04/2003US20030225092 E.g., 6-Benzo(1,3)dioxol-5-yl-10-hydroxy-2-methyl-2,3,6,7,12, 12a-hexa-hydropyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione potent and selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225090 Oxindole derivatives
12/04/2003US20030225089 Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
12/04/2003US20030225088 Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
12/04/2003US20030225086 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
12/04/2003US20030225085 For reducing neuronal cell death in response to a traumatic event
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225083 Oxazole derivatives, such as 3-(4-(2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy)-2-(pyridin-2-ylmethoxy) -phenyl)-propionic acid
12/04/2003US20030225082 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003US20030225079 Including oxy-substituted fused ring N-heterocyclic compounds, especially quinazolines, and the antibodies Cetuximab, Trastuzumab, ABX-EGF and Mab ICR-62
12/04/2003US20030225078 Derivatives of quinoline as alpha-2 antagonists
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225076 Mitogen ERK Kinase ("MEK") enzyme inhibitors
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225072 Opioid receptor active compounds
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225067 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (CNS) and/or in other parenchymal organs
12/04/2003US20030225066 Peritoneal dialysis solution with taurolidine
12/04/2003US20030225065 Use of 4-(1,4-diazepan-1-yl)- or 4-piperazin-1-yl-2-aminophenyl phenyl sulfones for treatment of disorders of the central nervous system.
12/04/2003US20030225064 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/04/2003US20030225063 Treating autoimmune diseases mediated by cathepsin S
12/04/2003US20030225062 Treating autoimmune diseases mediated by cathepsin S
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225060 Acylated piperidine derivatives as melanocortin-4 receptor agonists
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225058 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030225056 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/04/2003US20030225054 Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225051 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
12/04/2003US20030225050 Process for production of crystals of 11ss-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
12/04/2003US20030225049 Administering dehydroepiandrosterone sulfate to a human being of from 40 to 60 years of age for a period of at least 20 days.
12/04/2003US20030225048 Sulfatase inhibiting continuous progestogen contraceptive regimens
12/04/2003US20030225047 Sulfatase inhibiting progestogen-only contraceptive regimens
12/04/2003US20030225046 Through modulation of the interaction of such hormone receptors with phosphatidylinositol-3 kinase
12/04/2003US20030225045 Stabilizing kidney function in transplant patients undergoing immunosuppressive therapy
12/04/2003US20030225044 Administering vitamins to the animal's buccal cavity or nasal pharynx, such that the blood levels of each vitamin increase throughout a 6 hour period post-dosing; improving meat tenderness
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003US20030225041 Topical application to the eye of an acetylcholinesterase inhibitor such as echothiophate iodide to treat color blindness, ocular hypertension and glaucoma, and progression of myopia Strabismus Stargardts or pupil dilation.
12/04/2003US20030225040 Selective androgen receptor modulators and methods of use thereof
12/04/2003US20030225039 Method of treatment using bisphosphonic acid
12/04/2003US20030225038 Adenosine receptor antagonists and methods of making and using the same
12/04/2003US20030225037 Method for the treatment or prevention of Flaviviridea viral infection using nucleoside analogues
12/04/2003US20030225035 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
12/04/2003US20030225034 Preventing and treating vaginitis, preterm labor, post-operative pelvis infection, infertility, and sexually transmitted diseases with surfactant lipids, especially surfactant protein A
12/04/2003US20030225033 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof
12/04/2003US20030225032 Pharmaceutical composition
12/04/2003US20030225031 Liquid or gel solution for nasal administration also containing a permeation-enhancement agent for transmucosal drug uptake.
12/04/2003US20030225030 Non-liquid vitamin compositions
12/04/2003US20030225029 Dosing regimen for gemcitabine HCV therapy
12/04/2003US20030225028 Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B
12/04/2003US20030225020 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
12/04/2003US20030225011 Phospholipase A2 expression and activity and use thereof for diagnosis, prognostication, prevention and treatment of neural inflammatory and demyelinating disease
12/04/2003US20030225005 Inhibiting microbial growth within a mammal with a formulation containing Quercetin.
12/04/2003US20030225004 Use of LTB4 antagonists in veterinary medicine
12/04/2003US20030225003 Antimicrobial therapeutic compositions for oral and topical use
12/04/2003US20030225002 Aminosulfonyloxymethyl-substituted pyrans or cyclohexanes (e.g., topiramate) for relieving migraines and associated symptoms (nausea, vomiting, photophobia, phonophobia, etc.) administered with an antimigraine agent
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224971 Manufacture of polyglutamate-therapeutic agent conjugates
12/04/2003US20030224970 Methods for the identification of inhibitors of S-adenosylmethionine decarboxylase as antibiotics
12/04/2003US20030224517 Comprises oligonucleotides which inhibit secretase activity on amyloid precursor proteins (APP) for treating alzheimer's and neurodegenerative diseases
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224468 By interacting with periplasmic molecular chaperones the assembly of pili is prevented or inhibited and thereby the infectivity of the bacteria is diminished
12/04/2003US20030224466 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/04/2003US20030224423 Method of testing for allergic diseases
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224413 Comprises polynucleotides coding restriction fragment length polymorphism for use in identifying, characterizing and treatment of blood, respiratory, tumor and nervous system disorders
12/04/2003US20030224398 Purification of the leading front of migratory cells
12/04/2003US20030224383 Atherosclerotic phenotype determinative genes and methods for using the same
12/04/2003US20030224377 Novel LNA compositions and uses thereof
1 ... 5254 5255 5256 5257 5258 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 5271 5272 5273 5274 ... 7860